fwiw, basically technical analysis is just one of several factors that I consider when deciding to ADD to a position that I already own based on the fundamentals. If I let the technicals decide when to sell a stock, I probably would have been long gone out of ARIA by now and would have missed out on the 300+ percent move this stock has had since I've owned it. I'll let the pipeline decide what the long-term value of ariad is...but I know one thing,for me, it's a market cap significant north of current levels.
Does anyone really think MRK isn't going to file an NDA this year? After the rida cohort data is released at ASCO, imo, there isn't a chance that they won't file. The drug works. MRK is expanding the number of trials. The NDA is already all but written...just waiting to fill in the OS data and we'll be good to go.
Everything else is just noise.
